Paymentus (NYSE:PAY – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Paymentus has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.
Paymentus (NYSE:PAY – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The business services provider reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.03. The company had revenue of $197.42 million for the quarter, compared to analysts’ expectations of $180.57 million. Paymentus had a net margin of 4.63% and a return on equity of 9.33%. The business’s revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.06 EPS. On average, analysts expect Paymentus to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Paymentus Price Performance
Paymentus stock opened at $24.27 on Tuesday. The firm’s 50 day simple moving average is $22.40 and its 200-day simple moving average is $20.76. The company has a market cap of $3.02 billion, a P/E ratio of 97.08 and a beta of 1.41. Paymentus has a fifty-two week low of $14.77 and a fifty-two week high of $27.06.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on PAY
Paymentus Company Profile
Paymentus Holdings, Inc provides cloud-based bill payment technology and solutions in the United States and internationally. The company offers electronic bill presentment and payment services, enterprise customer communication, and self-service revenue management to billers through a software-as-a-service technology platform.
See Also
- Five stocks we like better than Paymentus
- What is MarketRank™? How to Use it
- Intel: Is Now the Time to Be Brave?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Breakout Stocks: What They Are and How to Identify Them
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Paymentus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paymentus and related companies with MarketBeat.com's FREE daily email newsletter.